Integra LifeSciences Holdings Corporation Launches a Zero-Profile, Stand-Alone Interbody Device for Neck Surgery

PLAINSBORO, N.J., Nov. 2, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the U.S. controlled market release of the Integra™ Complete Cervical Intervertebral Body Fusion Device (IBD), expanding Integra's spine product portfolio with the addition of its first zero-profile, stand-alone IBD cervical solution. The IntegraTM Complete Cervical IBD has received 510(k) clearance from the United States Food & Drug Administration (FDA), and is designed to help provide stability for spinal fusion after a diseased cervical disc is surgically removed.